当前位置:首页 - 行情中心 - 盘龙药业(002864) - 财务分析 - 现金流量表

盘龙药业

(002864)

  

流通市值:22.26亿  总市值:31.88亿
流通股本:7419.07万   总股本:1.06亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金865,685,539.67550,788,818.6269,984,389.551,044,752,555.62
  收到其他与经营活动有关的现金41,905,712.0139,486,047.0311,379,124.5645,712,792.35
  经营活动现金流入小计907,591,251.68590,274,865.63281,363,514.111,090,465,347.97
  购买商品、接受劳务支付的现金400,936,932.86247,045,554.54118,306,491.98361,518,733.53
  支付给职工以及为职工支付的现金63,973,419.9441,725,824.1319,802,243.4580,008,833.89
  支付的各项税费76,187,507.4653,745,884.1521,583,407.898,825,128.56
  支付其他与经营活动有关的现金277,337,443.09185,136,703.7995,706,644.76393,519,829.23
  经营活动现金流出小计818,435,303.35527,653,966.61255,398,787.99933,872,525.21
  经营活动产生的现金流量净额89,155,948.3362,620,899.0225,964,726.12156,592,822.76
二、投资活动产生的现金流量:
  取得投资收益收到的现金---2,000,000
  处置固定资产、无形资产和其他长期资产收回的现金净额283,204.171,769.91-4,613.91
  处置子公司及其他营业单位收到的现金净额---27,595.8
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计283,204.171,769.91-2,032,209.71
  购建固定资产、无形资产和其他长期资产支付的现金48,091,241.4331,076,298.3822,733,672.3582,051,105.9
  取得子公司及其他营业单位支付的现金---23,488,718.52
  投资活动现金流出小计48,091,241.4331,076,298.3822,733,672.35105,539,824.42
  投资活动产生的现金流量净额-47,808,037.26-31,074,528.47-22,733,672.35-103,507,614.71
三、筹资活动产生的现金流量:
  取得借款收到的现金50,000,00050,000,00050,000,000150,000,000
  筹资活动现金流入小计50,000,00050,000,00050,000,000150,000,000
  偿还债务支付的现金51,000,00050,500,00050,500,000100,500,000
  分配股利、利润或偿付利息支付的现金44,114,966.7932,789,761.335,835,501.2424,520,796.21
  支付其他与筹资活动有关的现金978,467.84865,827.84571,830.1510,702,074.94
  筹资活动现金流出小计96,093,434.6384,155,589.1756,907,331.39135,722,871.15
  筹资活动产生的现金流量净额-46,093,434.63-34,155,589.17-6,907,331.3914,277,128.85
五、现金及现金等价物净增加额-4,745,523.56-2,609,218.62-3,676,277.6267,362,336.9
  加:期初现金及现金等价物余额1,169,375,189.161,169,375,189.161,169,375,189.161,102,012,852.26
  期末现金及现金等价物余额1,164,629,665.61,166,765,970.541,165,698,911.541,169,375,189.16
补充资料:
  净利润-59,979,473.51-119,924,689.91
  资产减值准备-9,360,665.37-2,445,670.65
  固定资产和投资性房地产折旧-16,951,323.75-31,099,167.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,951,323.75-31,099,167.1
  无形资产摊销-719,016.38-1,411,366.08
  长期待摊费用摊销-277,842.57-479,640.71
  处置固定资产、无形资产和其他长期资产的损失-10,511.53-14,127.67
  固定资产报废损失-6,057.71-177,426.89
  财务费用-1,518,527.12-1,561,122.08
  投资损失-119,497.29--630,894.09
  递延所得税--2,067,369.53-2,079,604.32
  其中:递延所得税资产减少--2,859,166.27-1,314,412.96
    递延所得税负债增加-791,796.74-765,191.36
  存货的减少--5,891,974.3--18,207,683.6
  经营性应收项目的减少--89,927,886.5--12,483,486.28
  经营性应付项目的增加-70,974,270.94-29,157,685.2
  其他-590,943.18--891,598.47
  现金的期末余额-1,166,765,970.54-1,169,375,189.16
  减:现金的期初余额-1,169,375,189.16-1,102,012,852.26
  现金及现金等价物的净增加额--2,609,218.62-67,362,336.9
公告日期2025-10-282025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑